Rituximab |
CD 20 antibody |
EBV associated HLH |
Anakinra |
IL-1 receptor antagonist |
sJIA associated HLH |
Alemtuzumab |
CD 52 antibody |
Serotherapy in HSCT for
HLH |
Tocilizumab |
IL-6 receptor antagonist |
Trials ongoing |
Ruxolitinib |
JAK 1,2, receptor antagonist |
Trials
ongoing |
Emapalumab |
IFN gamma antibody |
Trials ongoing |
Adalimumab |
TNF alpha inhibitor |
Post-transplant associated
HLH |